RGNX - Regenxbio GAAP EPS of -$1.38 misses by $0.11 revenue of $15.62M misses by $7.9M
2024-05-08 16:51:21 ET
More on Regenxbio
- Regenxbio: DMD Program Lends Additional Credibility To NAV Technology Platform
- REGENXBIO Inc. (RGNX) Q4 2023 Earnings Call Transcript
- Regenxbio Q1 2024 Earnings Preview
- Regenxbio raised to Buy at RBC on pivot to Duchenne
- Seeking Alpha’s Quant Rating on Regenxbio